Interim report, foreign filer
Open the filing on sec.gov
Nyxoah SA (NYXH)
Nasdaq: NYXH · Surgical & Medical Instruments & Apparatus · filing with the SEC since 2021
The companyfiscal 2025, as filed
Revenuen/a
Net income-€90.1M-52.1%
Earnings per share€-2.36-30.7%
Operating cash flow-€69.0M-40.1%
Cash€30.0M-12.2%
Debtn/a
Shareholders’ equity€49.1M-56.6%
Shares, diluted38.1M+16.4%
Return on equity-183.4%
The recordfrom its filings
Filings in 202623
Newest filingNov 5 · 6-K
Annual reportMar 26, 2026
Quarterly reportn/a
Next report due20-F by Apr 30
Insider sales, 12 months$0.00
Insider buys, 12 months$0.00
Patents granted67
Filer categoryAccelerated filer<br>Emerging growth company
Left: the newest annual report, with the change on the year before. Right: counted from the company's own filings with the SEC.
As filed, in EUR. Nothing here is a forecast.
News
Interim report, foreign filer
Open the filing on sec.gov
Interim report, foreign filer
Open the filing on sec.gov
Interim report, foreign filer
Open the filing on sec.gov
Large holder update, amended
Open the filing on sec.gov
Interim report, foreign filer
Open the filing on sec.gov
Interim report, foreign filer
Open the filing on sec.gov
Large holder update, amended
Open the filing on sec.gov
Interim report, foreign filer
Open the filing on sec.gov
Large holder notice
Open the filing on sec.gov
Nothing of this kind is on the record for this company yet.
An outside story is shown by its headline, its source and its link only. The SI reads the page when you ask it to break one down.